COMPARISON OF TWO WIDELY USED ATYPICAL ANTIPSYCHOTICS OLANZAPINE VERSUS RISPERIDONE IN TERMS OF METABOLIC OUTCOMES

par Shiraz Hussain, Nomita Imtiaz, Malik Awais Amin, Sana Khan, Siddique Kakar
Publié 2021

Case Report: Cariprazine Efficacy in Young Patients Diagnosed With Schizophrenia With Predominantly Negative Symptoms

par Octavian Vasiliu
Publié 2021

Use of atypical antipsychotics in the elderly: a clinical review

par Gareri P, Segura-Garcia C, Manfredi VG, Bruni A, Ciambrone P, Cerminara G, De Sarro G, De Fazio P
Publié 2014

Lack of tolerable treatment options for patients with schizophrenia

par Citrome L, Eramo A, Francois C, Duffy R, Legacy SN, Offord SJ, Krasa HB, Johnston SS, Guiraud-Diawara A, Kamat SA, Rohman P
Publié 2015

Atypical antipsychotics as add-on treatment in late-life depression

par Cakir S, Senkal Z
Publié 2016

A Random Forest Model for Predicting Social Functional Improvement in Chinese Patients with Schizophrenia After 3 Months of Atypical Antipsychotic Monopharmacy: A Cohort Study

par Li Y, Zhang L, Zhang Y, Wen H, Huang J, Shen Y, Li H
Publié 2021

Brexpiprazole for the maintenance treatment of adults with schizophrenia: an evidence-based review and place in therapy

par Ward K, Citrome L
Publié 2019

Neuroleptic-induced deficit syndrome in bipolar disorder with psychosis

par Ueda S, Sakayori T, Omori A, Fukuta H, Kobayashi T, Ishizaka K, Saijo T, Okubo Y
Publié 2016

Taiwan Expert Consensus Recommendations for Switching to Aripiprazole Long-Acting Once-Monthly in Patients with Schizophrenia

par Chih-Sung Liang, Tung-Ping Su, Ming-Hsien Hsieh, Chau-Shoun Lee, Joseph Kuo, Nan-Ying Chiu, Po-See Chen, Yung-Chieh Yen, Ya-Mei Bai
Publié 2021

Pharmacological Treatment of Bipolar Depression: What are the Current and Emerging Options?

par Yalin N, Young AH
Publié 2020

Effects of Lithium Combined with Second-Generation Antipsychotics for the Treatment of Manic Episodes in Patients with Bipolar Disorder: A Naturalistic Study in China

par Liu Y, Liang J, Xia Q, Zhou X, Xie X
Publié 2020

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies

par Barabássy Á, Sebe B, Acsai K, Laszlovszky I, Szatmári B, Earley WR, Németh G
Publié 2021

Safety and Tolerability of Cariprazine in Patients with Schizophrenia: A Pooled Analysis of Eight Phase II/III Studies [Corrigendum]

par Barabássy Á, Sebe B, Acsai K, Laszlovszky I, Szatmári B, Earley WR, Németh G
Publié 2021

Post hoc analyses of asenapine treatment in pediatric patients with bipolar I disorder: efficacy related to mixed or manic episode, stage of illness, and body weight

par Findling RL, Earley W, Suppes T, Patel M, Wu X, Chang CT, McIntyre RS
Publié 2018

No association between BDNFVal66Met polymorphism and treatment response in obsessive-compulsive disorder in the Japanese population

par Umehara H, Numata S, Kinoshita M, Watanabe S, Nakaaki S, Sumitani S, Ohmori T
Publié 2016